cilastatin has been researched along with Reperfusion Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hong, YA; Hwang, HS; Im, DS; Jeong, KH; Jung, SY; Park, CW; Yang, KJ | 1 |
1 other study(ies) available for cilastatin and Reperfusion Injury
Article | Year |
---|---|
Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Cilastatin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Ischemic Preconditioning; Kidney; Male; Mice; Mice, Inbred C57BL; Protective Agents; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Signal Transduction; TOR Serine-Threonine Kinases; Ubiquitination; Up-Regulation | 2020 |